|
Laboratory Management
Citations 281-290 of 609 total displayed.
|
Past content
(since Jan 1997):
|
- Enzymes and Protein Markers
Lower Cardiac Troponin T and I Results in Heparin-Plasma Than in Serum
- Hugo Stiegler, Yuriko Fischer, Jaime F. Vazquez-Jimenez, Jürgen Graf, Karsten Filzmaier, Bernd Fausten, Uwe Janssens, Axel M. Gressner, and Dagmar Kunz
Clin. Chem. 2000; 46: 1338-1344.
[Abstract]
[Full text]
[PDF]
- Hematology
Stability of Common Analytes in Urine Refrigerated for 24 h before Automated Analysis by Test Strips
- Paul Froom, Barbara Bieganiec, Zahava Ehrenrich, and Mira Barak
Clin. Chem. 2000; 46: 1384-1386.
[Abstract]
[Full text]
[PDF]
- Laboratory Management
Reminders of Drug Effects on Laboratory Test Results
- Marita Kailajärvi, Timo Takala, Paula Grönroos, Nils Tryding, Jorma Viikari, Kerttu Irjala, and Jari Forsström
Clin. Chem. 2000; 46: 1395-1400.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Uncertainty of Measurement in Clinical Laboratory Sciences
- Xavier Fuentes-Arderiu
Clin. Chem. 2000; 46: 1437-1438.
[Extract]
[Full text]
[PDF]
- Editorials
Interferences in Immunoassay—Still a Threat
- Larry J. Kricka
Clin. Chem. 2000; 46: 1037-1038.
[Extract]
[Full text]
[PDF]
- Reviews
Evidence-based Laboratory Medicine: Supporting Decision-Making
- Christopher P. Price
Clin. Chem. 2000; 46: 1041-1050.
[Abstract]
[Full text]
[PDF]
- Evidence-based Laboratory Medicine and Test Utilization
Analytical Quality of Near-Patient Blood Cholesterol and Glucose Determinations
- Marita du Plessis, Johan B. Ubbink, and W.J. Hayward Vermaak
Clin. Chem. 2000; 46: 1085-1090.
[Abstract]
[Full text]
[PDF]
- Evidence-based Laboratory Medicine and Test Utilization
Opportunistic Discovery of Occult Disease by Use of Test Panels in New, Symptomatic Primary Care Outpatients: Yield and Cost of Case Finding
- Yuzuru Takemura, Haku Ishida, Yuji Inoue, Hiroyuki Kobayashi, and J. Robert Beck
Clin. Chem. 2000; 46: 1091-1098.
[Abstract]
[Full text]
[PDF]
- Enzymes and Protein Markers
Description of a Computer Program to Assess Cancer Antigen 15.3, Carcinoembryonic Antigen, and Tissue Polypeptide Antigen Information during Monitoring of Metastatic Breast Cancer
- György Sölétormos and Vibeke Schiøler
Clin. Chem. 2000; 46: 1106-1113.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Evidence-based Implementation of Free Phenytoin Therapeutic Drug Monitoring
- Martha Burt, David C. Anderson, Julie Kloss, and Fred S. Apple
Clin. Chem. 2000; 46: 1132-1135.
[Abstract]
[Full text]
[PDF]
|
|
